Genetic Diseases
Caused due to mutations.
Which leads to defective formation of gene product.
Deficiency of product- Hemophilia (factor VIII deficiency)
Defective metabolism for eg:- Galactosemia, Phenylketonuria, Hemochromatosis.
Enzyme defect due to genetic abnormalities.
1st approved gene therapy- GLYBERA.(2012 discontinued)
Genetic disorders are managed by:-
Replacement of a deficient product. (factor VIII)
Dietary restrictions of such product which accumulates and causes disease.
But if the cause is deficiency of enzyme then it is difficult to replace as the sources of enzyme are limited, and also it is difficult to target to the specific organ where it should be utilized.
Several needs to be satisfied:-
Prognosis of disease
Genetic disease is due to well characterized single gene defect. Gene is isolated & fully characterized with defined regulatory elements.
Target cell and delivery method.
Enough evidence that gene encorporated via gene therapy will function. And product formed will not harmful.
Gene replacement
Gene correction
Gene augmentation
(only method used currently)
Vectors used in the gene therapy Retroviral vectors (carry DNA insert up to 9kbp)
Adenoviral vectors (carry up to 7.5 kbp)
Plasmid liposome complex
In- vivo gene therapy
( CFTR gene is introduced as aerosol in Respiratory tract)
Ex-vivo gene therapy
In- utero gene therapy
It is feasible.
It is safe but long term outcome need to be evaluated.
Not immunological in nature (causes inflammation).
Results are variable but encouraging.
Conceptualized in 1972, Firstly tried in 1990, >1700 clinical trials have been conducted.
The following diseases have notable advances:-
SCID- Adenosine Deaminase deficiency
Chronic granulomatous diseases.
Hemophilia
Cancers
Neurodegenerative diseases (Parkinson’s disease, Huntington’s disease)
Hepatitis, HIV, Influenza
Coronary Artery Disease & Heart Failure
Blindness- Retinitis Pigmentosa
Muscular dystrophy etc.
RFLP- Restriction Fragment Length Polymorphism It is an enzymatic procedure, for separation and identification of desired fragments of DNA.
Using RE enzymes fragments of DNA is obtained and the desired fragment is detected by using restriction probes.
Used to differentiated two organism by analysis of patterns derived from cleavage of their DNA. (VNTR are 10-60bps oligonucleotides sequences also k/s minisatellites, repeated 20 to 100 times & 1-4 bps short tandem repeats k/s microsatellites).
RFLP is a technique invented in 1984 by scientist Alec Jeffrey during research into hereditary diseases.
Genetic polymorphism is defined as the inherited genetic differences among individuals in over 1% of normal population.
The RFLP technique exploits these differences in DNA sequences to recognize and study both intraspecies and interspecies variation.
Step I:
Restriction digest
Extraction of desired fragments of DNA using restriction endonuclease (RE).
TRY TO COVER 4 TOPICS IN 40 MIN. ALL THE BEST.
UChicago CMSC 23320 - The Best Commit Messages of 2024
GENE THERAPY, RFLP, DNA Fingerprinting.pptx
1. Gene Therapy, RFLP, DNA
Fingerprinting, Mutations
Dr. Abhinav Manish
MBBS, MD
Asst. Prof. Dept. of Biochemistry
GBCM
2. Gene Therapy
• Genetic Diseases
– Caused due to mutations.
– Which leads to defective
formation of gene product.
• Deficiency of product- Hemophilia
(factor VIII deficiency)
• Defective metabolism for eg:-
Galactosemia, Phenylketonuria,
Hemochromatosis.
• Enzyme defect due to genetic
abnormalities.
– 1st approved gene therapy-
GLYBERA.(2012 discontinued)
3. Cntd.
• Genetic disorders are managed by:-
– Replacement of a deficient product. (factor VIII)
– Dietary restrictions of such product which
accumulates and causes disease.
– But if the cause is deficiency of enzyme then it is
difficult to replace as the sources of enzyme are
limited, and also it is difficult to target to the
specific organ where it should be utilized.
4. Pre-requisite of Gene Therapy
• Several needs to be satisfied:-
– Prognosis of disease
– Genetic disease is due to well characterized single
gene defect. Gene is isolated & fully characterized
with defined regulatory elements.
– Target cell and delivery method.
– Enough evidence that gene encorporated via gene
therapy will function. And product formed will not
harmful.
5. Types of gene therapy
Gene replacement
Gene correction
Gene augmentation
(only method used currently)
6. Vectors used in the gene therapy
• Retroviral vectors (carry DNA insert up to 9kbp)
• Adenoviral vectors (carry up to 7.5 kbp)
• Plasmid liposome complex
7. Introduction of the vector
In- vivo gene therapy
( CFTR gene is introduced as aerosol in
Respiratory tract)
Ex-vivo gene therapy
In- utero gene therapy
8. Outcome of Gene Therapy
• It is feasible.
• It is safe but long term outcome need to be
evaluated.
• Not immunological in nature (causes
inflammation).
• Results are variable but encouraging.
9. Current status of Gene Therapy
• Conceptualized in 1972, Firstly
tried in 1990, >1700 clinical
trials have been conducted.
• The following diseases have notable
advances:-
– SCID- Adenosine Deaminase
deficiency
– Chronic granulomatous diseases.
– Hemophilia
– Cancers
– Neurodegenerative diseases
(Parkinson’s disease,
Huntington’s disease)
– Hepatitis, HIV, Influenza
– Coronary Artery Disease & Heart
Failure
– Blindness- Retinitis Pigmentosa
– Muscular dystrophy etc.
Disease Gene transferred by
SCID By Retrovirus, ADA enzyme
in ch.13&20 in lymphocyte
Duchenne Muscular
Dystrophy (DMD)
By Retrovirus,
Dystrophin gene on X.
CF CFTR gene ch. 7, by
Adenovirus
Familial
hypercholesterolemia
LDL receptor gene on
ch19, by retrovirus.
Hemophilia A & B gene for factor 8 & 9
in fibroblast, by retrovirus
Cancer Activation of p53, by
Liposome
Leber,s Hereditary
Optic Neuropathy
Adenoviral vector to
retina.
10. RFLP- Restriction Fragment Length
Polymorphism
• It is an enzymatic procedure, for separation and
identification of desired fragments of DNA.
• Using RE enzymes fragments of DNA is obtained
and the desired fragment is detected by using
restriction probes.
• Used to differentiated two organism by analysis
of patterns derived from cleavage of their DNA.
(VNTR are 10-60bps oligonucleotides sequences
also k/s minisatellites, repeated 20 to 100 times
& 1-4 bps short tandem repeats k/s
microsatellites).
11. Cntd.
• RFLP is a technique invented in 1984 by
scientist Alec Jeffrey during research into
hereditary diseases.
• Genetic polymorphism is defined as the
inherited genetic differences among
individuals in over 1% of normal population.
• The RFLP technique exploits these differences
in DNA sequences to recognize and study both
intraspecies and interspecies variation.
12. Procedure of RFLP
• Step I:
– Restriction digest
– Extraction of desired fragments of DNA using restriction
endonuclease (RE).
– The enzyme RE has specific restriction site on the DNA,
so it cut DNA into fragments. Different size of fragments
are generated along with the specific desired fragments
• Step II:
– Gel electrophoresis
– The digested fragment are run in electrophoresis to
separate the fragments on the basis of length or size or
molecular weight.
– Different size of fragments form different bands.
13. • Step III: Denaturation
– The gel is placed in sodium hydroxide (NaOH) solution
for Denaturation so that single stranded DNA are
formed.
• Step IV: Blotting
– single stranded DNA obtained are transferred into
charge membrane i.e. Nitrocellulose paper by the
process called capillary blotting or electro-blotting.
• Step V: Baking and blocking
– The nitrocellulose paper transferred with DNA is fixed
by autoclaving.
– Then the membrane is blocked by using bovine serum
albumin or casein to prevent binding of labeled probe
nonspecifically to the charged membrane.
14. • Step VII: Hybridization and visualization
– The labeled RFLP probe is hybridized with DNA on
the nitrocellulose paper.
– The RFLP probes are complimentary as well as
labeled with radioactive isotopes so they form
color band.
– These color bands visualize by autoradiography.
15. Application of RFLP
• Determine the status of genetic diseases such
as Cystic Fibrosis in an individual.
• To determine or confirm the source of a DNA
sample such as in paternity tests or criminal
investigations.
• In genetic mapping to determine
recombination rates that show the genetic
distance between the loci.
• To identify a carrier of a disease-causing
mutation in a family.
16. DNA Fingerprinting (DNA Profiling)
• Each DNA profile is unique
• Sequence of nucleotides, repeated again and
again but different for person to person.
• When the number is not known, variable, or
irrelevant. It is known as VNTR.
• When b/w 10-60 = minisatellites
• When b/w 1-4= microsatellites or STRs.
• Introns contain block of repeated STRs.
• These STRs leads to variation in individuals.
17. • DNA fingerprinting technique was devised in
1985 by Alec Jaffrey at university of Leicester
in England, while working on the sequence
with in myoglobin gene.
DNA is extracted from the sample.
– SDS (sodium Dodecyl Sulphate detergent is used)
– DNA is in nucleus (folded, molded, packed with proteins)
– Proteinase K
Ethanol Precipitation
Cut with the restriction endonuclease.
Separation of DNA Fragments via electrophoresis
DNA fingerprint is obtained on nylon sheet by blotting
technique and compared.
19. Application of DNA Fingerprinting
• Used in criminal, Medical, Paternity problems.
• Violent murder or natural calamity, when
recognition become difficult
• Rape victims
• Inheritance cases
• Immigration
• In Food industry
• Cancer detection
• Pattern of DNA profile is compared with victim
and of suspect.
20. Mutation
• DNA damage, caused by any agent, which
leads to alteration in DNA sequence, which if
replicated and transmitted to future
generation, becomes permanent and such
inherited change in base sequence of genomic
DNA is K/S Genetic Mutation.